Home › Trial NCT04368273
Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer.
- Trial IDNCT04368273
- StatusUnknown
- PhasePhase 1/2
- Study typeInterventional
- SponsorPeking University Third Hospital
- Enrollment30
- Start date2020-05-08
- ConditionsCervical Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.